Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201304035 Principal Investigator: Cashen, Amanda
Title: A Phase 1/2 Study of ISIS 481464, an Antisense Oligonucleotide Inhibitor of STAT3, Administered to Patients with Advanced Cancers
Phase: I/II Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to test how well study patients tolerate different doses of ISIS 481464 (the study drug) and to find out what effects, good or bad, ISIS 481464 has on the cancer.
 
More Information:
clinicaltrials.gov link
Internal Protocol Documents (requires Siteman administrative database password)